Results 111 to 120 of about 45,706 (160)

Ensaios clínicos e indústria farmacêutica

Cadernos de Saúde Pública, 2013
Suely Rozenfeld
doaj   +1 more source

[Interns and the pharmaceutical industry]. [PDF]

Aten Primaria, 2007
Martín-Aranda P, Vázquez I, Rodríguez de Cossío A.   +2 more
europepmc   +1 more source

Correction: Challenges to Establishing Pharmaceutical Medicine as a Profession: Needs for Professional Identity and a Career Pathway: Role of Education and Training. [PDF]

Pharmaceut Med
Silva H, Baroutsou V, Criscuolo D, Guptha S, Jurczynska A, Kerpel-Fronius S, Klech H, Klingmann I.   +7 more
europepmc   +1 more source

Position Statement on Cardiometabolic Health Across the Woman's Life Course - 2025. [PDF]

Arq Bras Cardiol
Oliveira GMM, Almeida MCC, Valério CM, Giuffrida F, Espíndola Neto L, Izar MCO, Marques-Santos C, Freire CMV, Albuquerque CJDM, Chagas ACP, Précoma DB, Mesquita ET, Saraiva JFK, Costa MENC, Lemke VMG, Lucena AJG, Brandão AA, Paiva Fagundes Junior AA, Macedo AVS, Polanczyk CA, Leitão CB, Silveira DS, Coutinho EDR, Nahas EAP, Alexandre ERG, Campana EMG, Bragança EOV, Colombo FMC, Barbosa ICQ, Rivera IR, Kulak Junior J, Salles JEN, Sá JR, Soares Júnior JM, Dourado LA, Moura LZ, Magalhães LBNC, Pompei LM, Passaglia LG, Assad MHV, Rodrigues MAH, Rivera MAM, Lopes MAAAM, Paiva MSMO, Castro ML, Campos MDSB, Souza OF, Medeiros OO, Freitas RAP, Carvalho RCM, Silva SCTFD, Rodrigues TCV, Avila WS, Silva Júnior WSD, Nazima WI, Costa-Paiva LHSD, Wender MCO.   +56 more
europepmc   +1 more source

[Substandard and falsified medical products: 25 years of successful network collaboration among regulatory authorities in the AmericasProdutos médicos de qualidade inferior e falsificados: 25 anos de colaboração bem-sucedida em rede entre autoridades reguladoras da Região das Américas]. [PDF]

Rev Panam Salud Publica
Vahos Zambrano J, Carrasco G, Rojas-Cortés R, Alfonso MJ, Viñas R, Derecho M, Munguía M, Marin D, Castro JL, Pombo-Castro ML.   +9 more
europepmc   +1 more source

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]

Arq Bras Cardiol
Rached FH, Miname MH, Rocha VZ, Zimerman A, Cesena FHY, Sposito AC, Santos RDD, Behr PEB, Bianco HT, Alves RJ, Faludi AA, Coutinho EDR, Fonseca FAH, Carvalho LSF, Bertolami A, Rocha AMD, Marte AP, Chagas ACP, Caramelli B, Polanczyk CA, Ferreira CEDS, Serrano Junior CV, Araujo DB, Moriguchi EH, Pinto FJ, Moreira HG, Back IC, Faria Neto JR, Maia KAP, Bertolami MC, Assad MHV, Izar MCO, Barreto MA, Barreto NSF, Silva PGMBE, Pimentel Filho P, Maranhão RC, Kaiser SE, Machado VA, Saraiva JFK.   +39 more
europepmc   +1 more source

La cooperazione tra gli stakeholder per la sostenibilità del nuovo paradigma farmaceutico in Italia. [PDF]

Glob Reg Health Technol Assess
Drago V, Di Brino E, Laurita R, Rumi F, Basile M, Pierini A, Ponzianelli A, Patarnello F, Ianna P, Drago F.   +9 more
europepmc   +1 more source

[Pharmaceutical services in expanded access, compassionate use, and post-trial access: the perspective of clinical researchers]. [PDF]

Cad Saude Publica
Silva MBFCD, Silva CFD, Silva MJSD.
europepmc   +1 more source

Medicamentos Manipulados em Pediatria: Estado Actual e Perspectivas Futuras [PDF]

, 2008
Carlos Maurício Barbosa, Susana Pinto
core  

Savings to the Colombian health system with the implementation of externally funded oncology clinical trials [PDF]

Biomedica
Aruachan Vesga S, González M, Rojas DM, Ospina J, Duque-Varela S, Castaño AÁ.   +5 more
europepmc   +1 more source